In a recent press release, Biomed Devices announced their intention to take over Pharmacore Industries in a 1 for 1 stock swap. A merger arbitrage hedge fund manager noticed that prior to the announcement, Biomed’s stock was trading at $121 per share, while Pharmacore’s stock was trading at $98 per share. After the merger announcement, Biomed’s stock dropped to $112 per share, while Pharmacore’s stock climbed to $107 per share. Which of the following best identifies the appropriate merger arbitrage strategy and potential profit once the deal is complete? A. Buy Pharmacore Industries, short sell Biomed Devices; Profit = $5.00. B. Buy Pharmacore Industries, short sell Biomed Devices; Profit = $9.00. C. Buy Biomed Devices, short sell Pharmacore Industries; Profit = $9.00. D. Buy Biomed Devices, short sell Pharmacore Industries; Profit = $5.00.